Clinical trial

Nevirapine Study for the Prevention of Maternal-Infant HIV Transmission in Uganda

NCT00639938

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Mapped RxNorm record Nevirapine Normalized identity: nevirapineView linked drug · Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention HIV immune globulin solution Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Nevirapine Study for the Prevention of Maternal-Infant HIV Transmission in Uganda

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE3

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2004-07-01

PhasePHASE3

Conditions

HIV Infectionsunresolved

Interventions

NevirapineDRUG · verified · RxNorm: nevirapine

HIV immune globulin solutionDRUG

Sponsors & collaborators

National Institute of Allergy and Infectious Diseases (NIAID)lead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00639938 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.